Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
60%
Mouse
20%
Human Alphaherpesvirus 1
20%
Omicron Coronavirus Variant
17%
Viral Load
16%
Influenza
14%
COVID-19
14%
Virus Infectivity
12%
Lineages
11%
Vaccine Efficacy
10%
Viral Replication
10%
Viral Disease
9%
Dynamics
9%
Genomic Surveillance
9%
Respiratory Virus
9%
Vaccination Policy
8%
Whole Genome Sequencing
8%
Breakthrough Infection
8%
Cycle Threshold
8%
Infectious Agent
7%
Next Generation Sequencing
7%
T Cell
7%
Escherichia coli
7%
Orthopoxvirus
7%
Enterovirus D68
7%
Human Immunodeficiency Virus
7%
Plasmid
7%
Cell Culture
7%
Immune Response
6%
Wild Type
6%
Upper Respiratory Tract
6%
Spike
6%
Droplet Digital Polymerase Chain Reaction
6%
Hemagglutinin
6%
Monkeypox
5%
Pathogenicity
5%
Genotype
5%
Influenza B Virus
5%
Amino Terminal Sequence
5%
Human Immunodeficiency Virus 1
5%
Sendai Virus
5%
Human Adenovirus C
5%
Explant
5%
Keyphrases
COVID-19
55%
Herpes Simplex Virus Type 1 (HSV-1)
20%
Maryland
16%
Mpox
13%
Virus
11%
Baltimore
10%
United States
10%
SARS-CoV-2 Infection
9%
Genomic Surveillance
9%
Viral Replication
8%
Infected Cell Protein 0
8%
Genome Sequencing
8%
Infectious Virus
7%
Point-of-care
7%
Pregnant Women
7%
Respiratory Viruses
7%
Clinical Outcomes
6%
Viral
6%
Orthopoxvirus
6%
Cycle Threshold
6%
Immunodeficient Mice
6%
SARS-CoV-2 Variants
6%
Saliva
5%
COVID-19 Pandemic
5%
Johns Hopkins
5%
Unvaccinated
5%
E3 Ubiquitin Ligase
5%
Hospitalization
5%
Respiratory Syncytial Virus
5%
Viral Genome
5%
Influenza
5%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
5%
Delta Variant
5%
Phosphorylation Sites
5%
Droplet Digital PCR (ddPCR)
5%
Enterovirus D68 (EV-D68)
5%
Pre-exposure Prophylaxis (PrEP)
5%
Virus Diseases
5%
Multiplexing
5%
Respiratory Pathogens
5%
Human Adenovirus (HAdV)
5%
Virus Infection
5%
Influenza B Virus
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
47%
COVID-19
46%
Diagnosis
14%
Outpatient
12%
Pathogen
10%
Whole Genome Sequencing
8%
Symptom
8%
Omicron Coronavirus Variant
7%
Human Immunodeficiency Virus
7%
Disease
7%
Virus Infectivity
6%
Severe Acute Respiratory Syndrome
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Coronavirinae
5%
Virus RNA
5%
Influenza
5%
Nasopharyngeal Swab
5%
Pandemic
5%
Human Adenovirus C
5%
Mixed Infection
5%
Virus Infection
5%
Serositis
5%
